The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution   Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)     Arif Hussain Consulting or Advisory Role - AstraZeneca; Bayer; Exelixis; Janssen Oncology; Merck Research Funding - AstraZeneca (Inst); Bayer (Inst); FutureChem (Inst); Merck (Inst); Orion (Inst); POINT Biopharma (Inst); Poseida Therapeutics (Inst); Regeneron (Inst)   Fred Saad Honoraria - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; BMS; GlaxoSmithKline; Janssen Oncology; Knight Therapeutics; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi; Sumitomo Dainippon Pharma Oncology; Tolmar Consulting or Advisory Role - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca/MedImmune; Bayer; GlaxoSmithKline; Janssen Oncology; Knight Therapeutics; Myovant Sciences; Novartis; Pfizer; Sanofi; Sumitomo Dainippon Pharma Oncology; Tolmar Research Funding - Abbvie (Inst); Advanced Accelerator Applications (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Point Therapeutics (Inst); Sanofi (Inst)   Hiroyoshi Suzuki Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Health; Bayer Yakuhin; Janssen Oncology; Janssen Research & Development; MSD K.K; Pfizer; Sanofi Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer Yakuhin; Janssen; Kissei Pharmaceutical; Novartis; Sanofi; Takeda Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer Yakuhin (Inst); Janssen (Inst); Lilly (Inst); MSD K.K (Inst)   Chris Garratt Employment - Orion Stock and Other Ownership Interests - Orion   Margarita Donica Employment - Merck   Yingjie Liu Employment - Merck   Kentaro Imai Employment - Merck Stock and Other Ownership Interests - Merck   Peter Fong Consulting or Advisory Role - Merck Sharp & Dohme